RESUMEN
Objective: To explore the correlation of serum lipids levels of Alzheimer's disease (AD) patients with sex, age and apolipoprotein E (Apo E) gene polymorphism. Methods: The retrospective study method was used, and 407 AD patients (142 males and 265 females, aged 52-91 years) were selected from Beijing Tiantan Hospital from January 2015 to August 2021 as the research target, and 894 healthy persons (339 males and 555 females, aged 52-94 years) who did body examination were selected as the control group. The AD patients were divided into four age groups according to the age interval of 10 years, including 85 aged 50-59 years, 163 aged 60-69 years, 119 aged 70-79 years, and 40 aged more than 80 years. The serum lipids levels were detected by biochemical analyzer, including triglycerides (TG), cholesterol (CHO), high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C), apolipoproteinA1(Apo A1) and apolipoprotein B (Apo B). ApoE gene polymorphism were detected by PCR fluorescent probe method. Mann-Whitney U test and Kruskal-Wallis H test were used to compare the serum lipids levels in each group. Results: The levels of serum CHO and LDL-C were 3.30(1.41,4.82) mmol/L and 1.76(1.39,2.78) mmol/L in AD patients, and 4.84(4.24, 5.56) mmol/L and 2.91(2.36, 3.57) mmol/L in control group, and the levels of serum CHO and LDL-C of AD patients were significantly lower than control group (Z=-15.172,Z=-14.583 , P<0.001, P<0.001). The levels of serum HDL-C and Apo B were 1.84(1.30, 3.88) mmol/L and 1.17(0.85, 1.57) g/L in AD patients, and 1.39(1.18, 1.64) mmol/L and 0.93(0.81, 1.09) g/L in control group, and the levels of serum HDL-C and Apo-B of AD patients were significantly higher than control group (Z=-12.249 , Z=-9.706 , P<0.001, P<0.001). There was no significant difference in TG and Apo A1 between 2 groups (Z=-1.577 , Z=-0.408 , P=0.115, P=0.683). The levels of TG, CHO, LDL-C in female AD patients were significantly higher than male patients (Z=-2.737 , Z=-3.963 , Z=-4.417, P=0.006, P<0.001, P<0.001). There were significant differences in TG, CHO, HDL-C, LDL-C, Apo A1 and Apo B among AD patients of all age groups (Z=11.263 , Z=10.060 , Z=40.246 , Z=10.451 , Z=24.315 , Z=19.922 , P=0.010 , P=0.018 , P<0.001 , P=0.015 , P<0.001 , P<0.001). The serum CHO and LDL-C levels were positively correlated with age (rs=0.160, rs=0.174, P=0.001, P<0.001), and HDL-C, Apo A1 and Apo B levels were negatively correlated with age (rs=-0.312, rs=-0.272, rs=-0.146, P<0.001, P<0.001, P=0.003), and there was no correlation between TG level and age in AD patients (rs=0.086, P=0.082). There were 3 cases (3.33%) of E2, 43 cases of E3 (47.78%) and 44 cases of E4 (48.89%) in AD patients, and 22 cases (12.72%) of E2, 117 cases of E3 (67.63%) and 34 cases of E4 (19.65%) in control group. There was significant difference in Apo E genotype distribution between AD patients and control group (χ²=26.381 , P<0.001). Apo E4 was the most common genotype in AD patients, and the proportion was 48.89%. Except for Apo A1(Z=7.821 , P=0.020), there was no significant difference in TG, CHO, HDL-C, LDL-C and Apo B levels among all patients with different genotypes (Z=3.732 , Z=1.677 , Z=1.455 , Z=1.619 , Z=2.202 , P=0.155, P=0.432, P=0.483, P=0.445, P=0.333). Conclusion: The levels of CHO and LDL-C decreased while the levels of HDL-C and Apo B increased in AD patients. The dyslipidemia in AD patients might be correlated with age, but not sex and Apo E genotypes.
Asunto(s)
Anciano , Anciano de 80 o más Años , Femenino , Humanos , Masculino , Persona de Mediana Edad , Enfermedad de Alzheimer/genética , Apolipoproteínas E/genética , HDL-Colesterol/sangre , Polimorfismo Genético , Estudios Retrospectivos , Triglicéridos/sangreRESUMEN
OBJECTIVE@#To investigate the significance of CD27 and CD56 in the prognosis of multiple myeloma (MM) patients, and to establish a simple and convenient prognostic risk score.@*METHODS@#One hundred and eleven newly diagnosed MM patients treated by bortezomib in Shengjing hospital from January 1, 2013 to January 1, 2019 were selected, and the relationship between clinical characteristics and survival time of patients was analyzed.@*RESULTS@#The overall survival (OS) of patients in CD27@*CONCLUSION@#Among patients with MM treated by bortezomib, CD27
Asunto(s)
Humanos , Bortezomib , Antígeno CD56 , Trasplante de Células Madre Hematopoyéticas , Mieloma Múltiple , Pronóstico , Estudios RetrospectivosRESUMEN
Aim To investigate the effect of resveratrol (RSV)on apoptosis of PC 12 cells induced by advanced glycation end products(AGEs) and its possible molecular mechanism. Methods MTS assay was used to detect the effects of AGEs (0, 50, 100, 200, 400 g • L"1) and RSV (0, 5, 10, 20, 40 jxmol • L"1) on cell viability. PC12 cells were treated with AGEs (400 g • L-1) and RSV (10 |xmol • L"1). TUNEL staining was used to detect apoptosis; flow cytometry was used to detect apoptosis and reactive oxygen species (ROS) ; Western blot was used to detect protein expression of p-JNK, JNK, PUMA, Bcl-2, Bax and Caspase-3. Apoptosis was observed by flow cytometry after pretreat- ment with JNK specific phosphorylation inhibitor (sp600125). Results Compared with normal control group, the cell viability of AGEs group decreased, the apoptotic rate and ROS levels increased, the expressions of p-JNK, PUMA, Bax and Caspase-3 protein in-creased, the expression of Bcl-2 protein decreased; Compared with AGEs group, the cell viability of the AGEs + RSV group increased, the levels of apoptotic rate and ROS were reduced, the expressions of p-JNK, PUMA, Bax and caspase-3 protein decreased, the expression of Bcl-2 protein increased. Sp600125 could partially reverse the effect of AGEs on PC)2 cell apopto-sis. Conclusions RSV can significantly inhibit the apoptosis of PC 12 cells induced by AGEs, which may be related to the activation of ROS-JNK pathway.
RESUMEN
BACKGROUND@#Patients with temporal lobe epilepsy (TLE) originating from different seizure onset zones had distinct electrophysiological characteristics and surgical outcomes. In this study, we aimed to investigate the relationship between the origin and prognosis of TLE, and the stereoelectroencephalography (SEEG) features.@*METHODS@#Thirty patients with TLE, who underwent surgical treatment in our functional neurosurgery department from January 2016 to December 2017, were enrolled in this study. All patients underwent anterior temporal lobectomy after an invasive pre-operative evaluation with SEEG. Depending on the epileptic focus location, patients were divided into those with medial temporal lobe seizures (MTLS) and those with lateral temporal lobe seizures (LTLS). The Engel classification was used to evaluate operation effectiveness, and the Kaplan-Meier analysis was used to detect seizure-free duration.@*RESULTS@#The mean follow-up time was 25.7 ± 4.8 months. Effectiveness was 63.3% for Engel I (n = 19), 13.3% for Engel II, 3.3% for Engel III, and 20.0% for Engel IV. According to the SEEG, 60.0% (n = 18) had MTLS, and 40.0% (n = 12) had LTLS. Compared with the MTLS group, the operation age of those with LTLS was significantly greater (26.9 ± 6.9 vs. 29.9 ± 12.5 years, t = -0.840, P = 0.009) with longer epilepsy duration (11.9 ± 6.0 vs. 17.9 ± 12.1 years, t = -1.801, P = 0.038). Patients with MTLS had a longer time interval between ictal onset to seizure (67.3 ± 59.1 s vs. 29.3 ± 24.4 s, t = 2.017, P = 0.008). The most common SEEG ictal pattern was a sharp/spike-wave rhythm in the MTLS group (55.6%) and low-voltage fast activity in the LTLS group (58.3%). Compared with the LTLS group, patients with MTLS had a more favorable prognosis (41.7% vs. 77.8%, P = 0.049). Post-operative recurrence was more likely to occur within three months after the operation for both groups, and there appeared to be a stable long-term outcome.@*CONCLUSION@#Patients with MTLS, who accounted for three-fifths of patients with TLE, showed a more favorable surgical outcome.
Asunto(s)
Humanos , Lobectomía Temporal Anterior , Electroencefalografía , Epilepsia del Lóbulo Temporal/cirugía , Técnicas Estereotáxicas , Resultado del TratamientoRESUMEN
Objective Influenza A (FluA) poses a serious threat to human health due to its high infectivity, viral variation and rapid progression. This study aimed to analyze the characteristics of T-lymphocyte subsets in patients with severe FluA and their role in the prognosis of the disease. Methods We collected the clinical data on 80 cases of severe FluA treated in our Department of Respiratory and Critical Diseases from January 2018 to May 2019, which were divided into a death group (n = 25) and a survival group (n = 55) based on 28-day survival after admission. Thirty-one of the patients were co-infected with other pathogens at admission, of whom 11 died and 20 survived within 28 days after admission. We compared the clinical characteristics, general laboratory results and T-lymphocyte subsets (CD3+T, CD4+T and CD8+T cells) between different groups and analyzed the factors influencing the prognosis of the disease using logistic regression and multivariate COX regression analyses. Results Compared with the patients in the survival group, those in the death group showed significantly decreased counts of lymphoid, CD3+T, CD4+T and CD8+T cells, albumins and globulins (P < 0.05), but increased levels of procalcitonin, blood urea nitrogen, serum creatinine and serum glutamic-oxaloacetic transaminase (P < 0.05). CD3+T, CD4+T and CD8+T cells and albumins were remarkably decreased in the co-infection death group in comparison with the co-infection survival group (P < 0.05). The area under the ROC curve for the count of CD4+T cells was 0.728 (95% CI: 0.605-0.850), with the best cut-off value of 1.70 × 108/L, a sensitivity of 80% and a specificity of 64%. The 28-day survival rate was significantly higher in the patients with CD4+T cells ≥ 1.70×108/L than in those with CD4+T cells < 1.70×108/L (83% vs 41%, P < 0.05). COX regression analysis showed age, respiratory failure and alanine transaminase to be the risk factors while the count of CD4+T cells (RR = 0.740, 95% CI: 0.572-0.958) to be a preventive factor for the death of the patients within 28 days after admission (P < 0.05). Conclusion The count of T-lymphocytes are closely correlated to the prognosis of severe FluA and the patients with a decreased count of CD4+T cells have a higher risk of death within 28 days after admission. The count of CD4+T cells can predict the 28-day prognosis of severe FluA.
RESUMEN
<p><b>OBJECTIVE</b>To investigate the application of percutaneous endoscopic gastrostomy (PEG) to patients with severe craniocerebral injury for the purpose of nutritional support therapy and pulmonary infection prevention.</p><p><b>METHODS</b>A total of 43 patients with severe craniocerebral injury admitted to our department from January 2008 to December 2012 received PEG followed by nutritional therapy. There were other 82 patients who were prescribed nasal-feeding nutrition. Nutrition status was evaluated by comparing serum albumin levels, and the incidence of pulmonary infection 1 week before and 2 weeks after operation was identified and compared.</p><p><b>RESULTS</b>Both PEG and nasal-feeding nutrition therapies have significantly elevated serum albumin levels (P<0.05). Serum albumin levels before and after nutritional therapies showed no significant difference between the two groups (P>0.05). The incidence of pulmonary infection in PEG group was significantly decreased compared with that in nasal-feeding nutrition group (P<0.05).</p><p><b>CONCLUSION</b>PEG is an effective method for severe craniocerebral injury patients. It can not only provide enteral nutrition but also prevent pulmonary infection induced by esophageal reflux.</p>
Asunto(s)
Humanos , Traumatismos Craneocerebrales , Terapéutica , Reflujo Gastroesofágico , Gastroscopía , Gastrostomía , Métodos , Enfermedades Pulmonares , Apoyo Nutricional , Albúmina SéricaRESUMEN
<p><b>OBJECTIVE</b>The management of secondary normal pressure hydrocephalus (sNPH) is controversial. Many factors may affect the surgery effect. The purpose of this study was to identify the possible factors influencing prognosis and provide theoretical basis for clinical treatment of sNPH.</p><p><b>METHODS</b>A retrospective study was carried out to investigate the results of 31 patients with sNPH who underwent ventriculoperitoneal shunt surgery from January 2007 to December 2011. We processed the potential influencing factors by univariate analysis and the result further by multivariate logistic regression analysis.</p><p><b>RESULTS</b>Factors including age, disease duration and Glasgow coma scale (GCS) score before surgery significantly influenced the prognosis of sNPH (P less than 0.05). Further logistic regression analysis showed that all the three factors are independent influencing factors.</p><p><b>CONCLUSION</b>Age, disease duration and GCS score before surgery have positive predictive value in estimating favorable response to surgical treatment for sNPH.</p>
Asunto(s)
Adulto , Femenino , Humanos , Masculino , Persona de Mediana Edad , Hidrocéfalo Normotenso , Cirugía General , Pronóstico , Estudios Retrospectivos , Factores de Riesgo , Resultado del Tratamiento , Derivación VentriculoperitonealRESUMEN
Objective To evaluate the effectiveness and safety of chronic hippocampus electrical stimulation in treatment of patients with temporal lobe epilepsy.Methods The patients with temporal lobe epilepsy who were not suitable for anterior temporal lobectomy were selected.The patients had a 6-month-seizure count as baseline frequency.Medtronic electrodes were implanted directed into the amygdalohippocampal foci.After electroencephalography recording and interval stimulation for one week,implantable pulse generators were implanted and began to stimulate chronically.Seizure frequency was counted in the follow up.The efficacy and side-effect were also detected.Results Two patients were selected according to the criteria.There was no obvious side effect except for transient dizziness in one patient.One patient had a seizure reduction of>80% in a 22-month follow-up (decreasing from 3-4 times/month to 2-3 times/month); the seizure time was shorten and severity was alleviated than before treatment The other patient had a seizure reduction of>50% in a 10-month follow-up (decreasing from 6-10 times/month to 3-6 times/month); the seizure time was shorten than before treatment with few secondary generalized tonic-clonic seizures.Conclusion Chronic hippocampus electrical stimulation is a safe treatment for some patients with temporal lobe epilepsy who are not suitable for anterior temporal lobectomy; it may be helpful in controlling the seizures.
RESUMEN
<p><b>OBJECTIVE</b>To assess zero drift of intraventricular and subdural intracranial pressure (ICP) monitoring systems.</p><p><b>METHODS</b>A prospective study was conducted in patients who received Codman ICP monitoring in the neurosurgical department from January 2010 to December 2011. According to the location of sensors, the patients were categorized into two groups: intraventricular group and subdural group. Zero drift between the two groups and its association with the duration of ICP monitor were analyzed.</p><p><b>RESULTS</b>Totally, 22 patients undergoing intraventricular ICP monitoring and 27 receiving subdural ICP monitoring were enrolled. There was no significant difference in duration of ICP monitoring, zero drift value and its absolute value between intraventricular and subdural groups (5.38 d+/-2.58 d vs 4.58 d+/-2.24 d, 0.77 mm Hg+/-2.18 mm Hg vs 1.03 mm Hg+/-2.06 mm Hg, 1.68 mm Hg+/-1.55 mm Hg vs 1.70 mm Hg+/-1.53 mm Hg, respectively; all P larger than 0.05). Absolute value of zero drift in both groups significantly rose with the increased duration of ICP monitoring (P less than 0.05) while zero drift value did not. Moreover, daily absolute value in the intraventricular group was significantly smaller than that in the subdural group (0.27 mm Hg+/-0.32 mm Hg vs 0.29 mm Hg+/-0.18 mm Hg, P less than 0.05).</p><p><b>CONCLUSION</b>This study demonstrates that absolute value of zero drift significantly correlates with duration of both intraventricular and subdural ICP monitoring. Due to the smaller daily absolute value, ICP values recorded from intraventricular system may be more reliable than those from subdural system.</p>
Asunto(s)
Anciano , Femenino , Humanos , Masculino , Persona de Mediana Edad , Ventrículos Cerebrales , Presión Intracraneal , Monitoreo Fisiológico , Estudios Prospectivos , Espacio SubduralRESUMEN
<p><b>BACKGROUND</b>Chronic kidney disease (CKD) is a growing public health problem with well-established risk factors. Other contributing factors, however, remain to be identified. Systemic inflammation in asthma plays a significant role in the development of other diseases. We therefore initiated a study to assess whether the growing prevalence of asthma is associated with an increase in the risk of CKD.</p><p><b>METHODS</b>We conducted a retrospective cohort study using data from 3015 patients with asthma aged 14 years and older who were registered and followed up in Asthma Control Study at the Department of Respiratory Medicine of three medical centers from 2005 to 2011. History, asthma control test (ACT), and asthma stage were used to assess the traits of asthma. CKD was defined as proteinuria and/or reduced estimated glomerular filtration rate (eGFR) (<60 ml×min(-1)×1.73 m(-2)) in two consecutive follow-up surveys. We used logistic regression models, adjusting for age, sex, and other confounding factor to determine associations between the traits of asthma and CKD. Kaplan-Meier curves were used to analyze patient outcomes.</p><p><b>RESULTS</b>A total of 2354 subjects with complete data were recruited for this study with mean age (45.4±10.4) years. After 6 years of follow-up, 9.6% (n = 227) of the analytic cohort developed proteinuria and 3.1% (n = 72) progressed to eGFR <60 ml×min(-1)×1.73 m(-2). The patients with >20 years asthma history, not well-controlled or persistent asthma patients had higher incidence of proteinuria and reduced eGFR compared with patients with ≤20 years asthma history, at least well-controlled or remission asthma, respectively. The multivariable adjusted OR for proteinuria and reduced eGFR in participants with persistent asthma was 1.49; (95% confidence interval (CI) 1.17-1.91) and 2.07 (95% CI 1.34-4.42). Compared to patients with no asthma traits, there was a significant risk (OR, 3.39; 95% CI 1.36-8.73) for those who met all three traits, including asthma history >20 years, not well-controlled and persistent stage, after adjusting for potential confounding factors.</p><p><b>CONCLUSIONS</b>In this retrospective cohort study, we found that persistent asthma was associated with an increased risk of CKD, which was independent of obesity, diabetes, hypertension, and other well-established risk factors. Future studies should be directed to elucidate the mechanisms underlying the association between asthma and CKD.</p>
Asunto(s)
Adulto , Femenino , Humanos , Masculino , Persona de Mediana Edad , Asma , Tasa de Filtración Glomerular , Fisiología , Insuficiencia Renal Crónica , Estudios Retrospectivos , Factores de RiesgoRESUMEN
<p><b>BACKGROUND</b>p73, a homologue of p53, has been located at chromosome 1p36-33, a region of frequently observed loss of heterozygosity in breast cancers. The objective of the present study was to investigate the function of p73 in Japanese with breast cancers.</p><p><b>METHODS</b>Sixty Japanese patients with breast cancer were assessed by polymerase chain reaction single strand confirmation polymorphism analysis and direct sequencing to detect the p73 allele. p73 mRNA levels were also determined in 40 out of 60 patients by reverse-transcriptional polymerase chain reaction.</p><p><b>RESULTS</b>We analyzed the entire open reading frame of the p73 gene by polymerase chain reaction single strand confirmation polymorphism and sequencing, and failed to identify any mutations of p73 in the encoding regions detected. Loss of heterozygosity of p73 was infrequent and only found in 9% of breast carcinomas. We revealed a few polymorphisms with a frequency of 13% - 29%, which had been reported previously. Down-regulation of p73 mRNA expression was observed in tumor tissues in comparison to the normal breast tissues. A significant inverse correlation was found between p73 transcripts and high histological grade, suggesting that down-regulated p73 expression could be related to poor prognosis in those patients.</p><p><b>CONCLUSION</b>Our results suggest that p73 may serve as a tumor suppressor gene and its expression plays a role in tumorigenesis in Japanese patients with breast cancer.</p>
Asunto(s)
Femenino , Humanos , Persona de Mediana Edad , Neoplasias de la Mama , Genética , Metabolismo , Patología , Carcinoma , Genética , Metabolismo , Patología , Proteínas de Unión al ADN , Genética , Pérdida de Heterocigocidad , Genética , Proteínas Nucleares , Genética , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Proteína Tumoral p73 , Proteína p53 Supresora de Tumor , Genética , Metabolismo , Proteínas Supresoras de Tumor , GenéticaRESUMEN
<p><b>OBJECTIVE</b>To study the effect of embelin on proliferation, differentiation and apoptosis of HL-60 cells and explore its possible mechanism.</p><p><b>METHODS</b>Different concentration of embelin were used to treat HL-60 cells. Cell growth curve was analysed by MTT assay, cell apoptosis by Annexin V/PI double staining and JC-1 dye. The differentiation of HL-60 cells was evaluated by expression of CD33, CD34, CD11b and CD14. Bone marrow cells (BMC) from nine patients with acute nonlymphocytic leukemia (ANML) were also studied.</p><p><b>RESULTS</b>Embelin induced differentiation of HL-60 cells with significant increase of CD14 and CD11b expression at 33.97µmol/L for 3 days (P < 0.01). Embelin induced apoptosis of HL-60 cells in a time- and dose-dependent manner, the apoptosis rates were (9.23 ± 0.05)%, (25.86 ± 0.30)% and (39.03 ± 0.07)% respectively at 339.67 µmol/L of embelin for 12-, 24- and 48-hours treatment (P < 0.05); the apoptosis rates were (0.07 ± 0.03)%, (7.43 ± 0.30)%, (14.01 ± 0.01)%, (25.52 ± 0.03)% and (39.15 ± 0.01)% respectively at 10.19, 33.97, 101.90, 339.67 and 1019.02 µmol/L of embelin for 24-hours culture (P < 0.05). Clusters of differentiation antigen on BMC from three acute promyelocytic leukemia patients showed significant changes at 33.97 µmol/L of embelin treatment for 3 days. Embelin induced apoptosis of BMCs from all the nine ANML patients at 33.97 µmol/L for 24 hour.</p><p><b>CONCLUSION</b>Embelin can inhibit proliferation and induce differentiation and apoptosis of HL-60 cells. The mechanism may be related to mitochondrial apoptosis pathway. Embelin at subtoxic concentration doesn't promote leukemia BMC differentiation, but at 339.67 µmol/L induces apoptosis of these cells.</p>
Asunto(s)
Humanos , Apoptosis , Diferenciación Celular , Proliferación Celular , Células HL-60 , Leucemia Promielocítica Aguda , MetabolismoRESUMEN
<p><b>BACKGROUND</b>Dysembryoplastic neuroepithelial tumor (DNT) is a rare benign neoplasm of the central nervous system affecting young people. A correct preoperative diagnosis is helpful for planning surgical strategies and improving prognosis. The purpose of this study was to characterize DNTs using magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) and to analyze the value of these two techniques in the diagnosis of DNTs.</p><p><b>METHODS</b>MR images of 13 patients with DNTs were reviewed retrospectively; and five of the patients also underwent MRS. Tumors were confirmed by surgery. The distribution, extension and signal features of the lesions were assessed, and the MRS results were analyzed.</p><p><b>RESULTS</b>All tumors were supratentorial. The cortex was the main area involved, with nine tumors located in the temporal lobe, three in the frontal lobe, and one on the boundary between the temporal and occipital lobes. All cases had decreased signal intensity on T1-weighted MR images and increased signal intensity on T2-weighted images. On fluid attenuated inversion recovery weighted images, the hyperintense "ring sign" and internal septation of the lesion were seen in 9 cases. Eight tumors had well-demarcated borders. Peritumoral edema or mass effect was absent in all cases. A contrast enhancement examination was performed in 9 cases. Contrast enhancement was absent in five cases, and four cases showed significant enhancement. The MRS showed a low N-acetylaspartate peak and a lack of elevated choline-containing component (Cho) or Cho-Cr ratio (Cho/Cr) in five patients.</p><p><b>CONCLUSIONS</b>The MRI findings of DNTs were stereotypical. The combination of MRI and MRS techniques were helpful in making a correct presurgical diagnosis.</p>
Asunto(s)
Adolescente , Adulto , Niño , Preescolar , Femenino , Humanos , Lactante , Masculino , Adulto Joven , Neoplasias Encefálicas , Patología , Imagen por Resonancia Magnética , Métodos , Espectroscopía de Resonancia Magnética , Métodos , Neoplasias Neuroepiteliales , Patología , Estudios RetrospectivosRESUMEN
<p><b>OBJECTIVE</b>To explore an effective method for treating Gentamicin-induced deafness and the mechanism.</p><p><b>METHODS</b>Guinea pigs were randomly divided into 5 groups: normal control group (group A), model group (group B), Ligustrazine group (group C), acupuncture group (group D) and Ligustrazine plus acupuncture group (group E). The group C, D and E were treated respectively by simple Ligustrazine, simple acupuncture at "Tinggong" (SI 19), "Yifeng" (TE 17), and "Waiguan" (TE 5), and Ligustrazine plus acupuncture. Ten days later, the auditory brainstem response (ABR) thresholds for the wave III , apoptosis and expressions of Bcl-2 and Bax proteins in the organ of Corti of the guinea pig were detected.</p><p><b>RESULTS</b>In the group E, the ABR threshold was significantly lower than that in the group C (P<0.05), and apoptotic cells, the expression of Bax protein and the ratio of Bax/Bcl-2 were lower than those in the group C and D in the organ of Corti, and Bcl-2 protein expression was increased.</p><p><b>CONCLUSION</b>Acupuncture at "Tinggong" (SI 19), "Yifeng" (TE 17), and "Waiguan" (TE 5) has a certain target-synergistic action on Ligustrazine and can increase therapeutic effect of Ligustrazine on Gentamicin-induced deafness, which are possible related with the inhibition of apoptosis, down-regulation of Bax expression and up-regulation of Bcl-2 expression.</p>
Asunto(s)
Animales , Femenino , Masculino , Terapia por Acupuntura , Antibacterianos , Toxicidad , Sordera , Terapéutica , Potenciales Evocados Auditivos del Tronco Encefálico , Gentamicinas , Toxicidad , Cobayas , Pirazinas , Usos TerapéuticosRESUMEN
<p><b>OBJECTIVE</b>To discuss the localizing methods for epileptogenic zone with intraoperative electrocorticography (ECoG) by comparing it with long-term intracranial EEG.</p><p><b>METHODS</b>Twenty-two patients was enrolled, who received epilepsy surgeries consecutively in our institute since April 2005 to August 2006. All patients underwent intracranial electrode implantations with long-term video-EEG monitoring before the resective surgeries and the postoperative pathologies were all proved to be focal cortical dysplasia. The extra-operative and ECoG digital EEGs were statistically analyzed and compared with each other, including interictal epileptic discharge (IED) frequency, amplitude and their correlations with ictal discharge (ID).</p><p><b>RESULTS</b>In the long-term intracranial EEG, significant difference was found between IED frequency derived from ID onset verus none-onset electrodes (Z = 12.213, P < 0.001), ROC analysis showed that IED frequency is a moderately good indicator for ID, the area under the ROC curve was 0. 758 (95% CI, 0.707-0.810). There was significant difference in IED amplitude between ID and none-ID electrodes (Z = 11.765, P < 0.001). The IED frequency was significantly lower during ECoG than during long-term extra-operative monitoring (rho = 0.518, P = 0. 014). A significant positive correlation in the IED frequency pattern was found between intra-operative ECoG and extra-operative recording when the average IED frequency was over 3 spikes /min. In ECoG, the correlation of IED with ID was similar in the 'frequent' (> or = 10 spikes/min) and 'occasional' (3-10 spikes/min) groups and very different in the 'rare' (< or = C3 spikes/min) group (rho = 0.408, P = 0.147).</p><p><b>CONCLUSIONS</b>The IED from long-term EEG recording had moderate correlation in frequency and amplitude with ID position. IED frequency was usually decreased on ECoG when compared with long-term monitoring. However, ECoG could reliably reflect the IED pattern and the correlations between IED with ID in term of frequency and amplitude in the long-term EEG monitoring, when IED frequency exceeded 3 spikes/min. Under this circumstance, IED could be used for localizing the epileptogenic zone.</p>
Asunto(s)
Adolescente , Adulto , Niño , Femenino , Humanos , Masculino , Corteza Cerebral , Electrodos Implantados , Electroencefalografía , Métodos , Epilepsias Parciales , Cirugía General , Monitoreo Intraoperatorio , Estudios RetrospectivosRESUMEN
<p><b>OBJECTIVE</b>To discuss the presurgical evaluation and surgical treatment of lesional temporal lobe epilepsy (LTLE).</p><p><b>METHODS</b>We retrospectively studied the patients whose MRI or CT showed lesions on one of the temporal lobes among patients who underwent epilepsy surgeries in our institute. All patients were divided into satisfactory and unsatisfactory group according to outcomes after operation. The characteristics of the lesions, neurophysiological features and results of pathologies were analyzed statistically.</p><p><b>RESULT</b>Favorable surgical outcome was obtained in 24 patients, the satisfactory rate was 75%. The lesions of 17 patients were cortical malformations and the satisfactory rate of this group was 65%, which was less favorable than that of tumor group, (87%). 21 patients with their lesions located within the border of standard temporal lobectomy, had better surgical outcome than the others whose lesions were beyond the border (P<0.05). The satisfactory rate of 8 patients with lesions located within mesial structure of temporal lobe was no different compared with that of the others who had lesions outside the mesial structure (P>0.05). There were 19 patients who had consistency of the location of the lesion on MRI with the focal interictal epileptiform discharges on scalp EEG in satisfactory group, while there were only 3 patients in unsatisfactory group (P<0.05).</p><p><b>CONCLUSION</b>For a LTLE patient, epilepsy surgery should be the first choice to be considered. Careful presurgical studies of the lesion, including its location, pathological property and neurophysiological characteristics, were very helpful for improving the surgical outcome.</p>
Asunto(s)
Adolescente , Adulto , Niño , Preescolar , Femenino , Humanos , Masculino , Persona de Mediana Edad , Epilepsia del Lóbulo Temporal , Patología , Cirugía General , Psicocirugía , Métodos , Estudios Retrospectivos , Lóbulo Temporal , Patología , Cirugía General , Resultado del TratamientoRESUMEN
<p><b>OBJECTIVE</b>To study the clinicopathologic features, immunophenotype and histogenesis of dysembryoplastic neuroepithelial tumor (DNT).</p><p><b>METHODS</b>Fourteen cases of DNT were retrieved from the archival files of the Department. The histopathologic features and immunohistochemical findings were retrospectively studied. The long-term follow-up data were analyzed.</p><p><b>RESULTS</b>Eleven of the 14 cases studied were located in the temporal lobe. Histologically, the tumor consisted of a heterogeneous admixture of neuronal and glial cells (including 1 simple form case, 8 complex form cases and 5 non-specific form cases). The specific glioneuronal element was seen in 9 cases. Variable degrees of cortical dysplasia (CD) were found in 10 out of the 11 cases which had sufficient tissue samples for thorough histologic examination. The morphologic appearance of CD included the presence of heterotopic neurons in molecular layer and/or white matter (7 cases), persistent subpial granular cell layer (4 cases), dyslamination (10 cases) and cellular abnormalities. Immunohistochemically, the oligodendroglial-like cells expressed Olig2. Some of which were positive for nestin, MAP-2, neurofilament and glial fibrillary acidic protein, but negative for NeuN. Long-term follow up revealed that 12 patients had class I postoperative seizure and 2 patients had class II seizure. No tumor recurrence was detected.</p><p><b>CONCLUSIONS</b>DNT is frequently associated with CD. The morphologic diagnosis can be confirmed by immunohistochemical study using a panel of antibodies.</p>
Asunto(s)
Adolescente , Adulto , Niño , Preescolar , Femenino , Humanos , Lactante , Masculino , Adulto Joven , Anticonvulsivantes , Usos Terapéuticos , Factores de Transcripción con Motivo Hélice-Asa-Hélice Básico , Metabolismo , Neoplasias Encefálicas , Metabolismo , Patología , Cirugía General , Epilepsia , Quimioterapia , Estudios de Seguimiento , Proteínas de Filamentos Intermediarios , Metabolismo , Malformaciones del Desarrollo Cortical , Patología , Proteínas Asociadas a Microtúbulos , Metabolismo , Neoplasias Neuroepiteliales , Metabolismo , Patología , Cirugía General , Proteínas del Tejido Nervioso , Metabolismo , Nestina , Factor de Transcripción 2 de los Oligodendrocitos , Oligodendroglía , Patología , Estudios RetrospectivosRESUMEN
<p><b>OBJECTIVE</b>To assess the therapeutic effect of ulinastatin on severe craniocerebral injuries and to explore its mechanism.</p><p><b>METHODS</b>There were 87 cases of severe brain injury in this series and they were either treated by ulinastatin (treatment group, 41 cases) or not (control group, 46 cases) besides routine managements. We estimated C-reactive protein, interleukin-6, superoxide dismutase, and endothelin from plasmas of all the cases on the 1st, 3rd, 5th, and 7th day after injury.</p><p><b>RESULTS</b>C-reactive protein level rose on the 1st and 3rd day after injury in the two groups, but descended in treatment group on the 5th and 7th day and was significantly lower than that in control group (P < 0.01). No significant difference was found for interleukin-6 in two groups during 1-5 days after injury, but on the 7th day, it decreased significantly in treatment group than control one (P < 0.01). Superoxide dismutase was higher in treatment group than control one in 5-7 days after injury (P < 0.01). Endothelin elevated on the 1st day after injury but dropped afterwards in the two groups, in which the level in treatment group was lower than that in control one. The incidence of gastrointestinal hemorrhage was lower in treatment group than control one (P < 0.01).</p><p><b>CONCLUSIONS</b>Ulinastatin has the function of protecting cerebral tissue, reducing the incidence of gastrointestinal hemorrhage, improving hepatic and renal function and prognosis.</p>
Asunto(s)
Adolescente , Adulto , Anciano , Femenino , Humanos , Masculino , Persona de Mediana Edad , Proteína C-Reactiva , Traumatismos Craneocerebrales , Sangre , Quimioterapia , Endotelinas , Sangre , Glicoproteínas , Usos Terapéuticos , Interleucina-6 , Sangre , Superóxido Dismutasa , Sangre , Inhibidores de Tripsina , Usos TerapéuticosRESUMEN
<p><b>OBJECTIVE</b>To evaluate the antiandrogenic effect of heterocyclic fungicide dimethachlon and its mechanism.</p><p><b>METHODS</b>A combination of in vivo and in vitro assays was selected. Hershberger assay was used to determine the antiandrogenic potential of dimethachlon in vivo. Six-week-old castrated male SD rats were administrated once daily for 7 days with testosterone propionate (TP, 100 micro g/d, sc) plus gavage doses of dimethachlon (50, 100 or 200 mg x kg(-1) x d(-1)), or procymidone (150 or 300 mg x kg(-1) x d(-1), positive control), or iprodione (100 mg x kg(-1) x d(-1), positive control), or flutamide (50 mg x kg(-1) x d(-1), positive control). Transcriptional activation assay in vitro was employed to determine the mechanism of antiandrogenic activity of dimethachlon. Human hepatoma liver cells HepG2 were transiently cotransfected with human androgen receptor (AR) expression plasmid and AR-dependent luciferase report plasmid. Transfected cells were exposed to various concentrations of dimethachlon or flutamide with or without dihydrotestosterone to induce the expression of luciferase gene.</p><p><b>RESULTS</b>In Hershberger assay, dimethachlon, as well as other known antiandrogens, caused decrease in weight of androgen dependent organs or tissues. In 200 mg/kg group, the weight of seminal vesicle, ventral prostate, dorsolateral prostate, Cowper's gland, and levator ani plus bulbocavernosus muscles decreased by 57.8%, 44.8%, 43.9%, 30.1%, and 34.1% respectively, but did not decrease in the vehicle control group. The order of their antiandrogenic potencies was: flutamide > procymidone > dimethachlon > iprodione. In transcriptional activation assay, dimethachlon could inhibit dihydrotestosterone-dependent AR activity in transfected HepG2 cells in dose-effect relationship. The inhibiting potency of dimethachlon was about 1/100 of that of flutamide.</p><p><b>CONCLUSION</b>Dimethachlon has antiandrogenic effect, and acts as an AR antagonist. Its antiandrogenic potency is lower than flutamide and procymidone, but higher than iprodione.</p>
Asunto(s)
Animales , Humanos , Masculino , Ratas , Aminoimidazol Carboxamida , Farmacología , Toxicidad , Antagonistas de Andrógenos , Farmacología , Toxicidad , Andrógenos , Sangre , Metabolismo , Peso Corporal , Compuestos Bicíclicos con Puentes , Farmacología , Toxicidad , Línea Celular Tumoral , Clorobencenos , Farmacología , Toxicidad , Relación Dosis-Respuesta a Droga , Flutamida , Farmacología , Toxicidad , Fungicidas Industriales , Farmacología , Toxicidad , Hidantoínas , Luciferasas , Genética , Metabolismo , Plaguicidas , Farmacología , Toxicidad , Plásmidos , Genética , Ratas Sprague-Dawley , Receptores Androgénicos , Genética , Metabolismo , Succinimidas , Farmacología , Toxicidad , TransfecciónRESUMEN
This paper expounds how the tractor for the fracture reduction works. The clinical results show that the traction apparatus is a labour-saving and time-saving orthopedic device with simple operation and few suffering to patients.